Systemic reactivation of otitis media with effusion in a rat model

Citation
Bs. Jewett et al., Systemic reactivation of otitis media with effusion in a rat model, OTO H N SUR, 121(1), 1999, pp. 7-12
Citations number
24
Categorie Soggetti
Otolaryngology
Journal title
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
ISSN journal
01945998 → ACNP
Volume
121
Issue
1
Year of publication
1999
Pages
7 - 12
Database
ISI
SICI code
0194-5998(199907)121:1<7:SROOMW>2.0.ZU;2-K
Abstract
OBJECTIVE: This study addresses the interaction of bacterial antigens, spec ifically peptidoglycan-polysaccharide (PG-PS) and lipopolysaccharide (LPS), in the induction and reactivation of mucoid middle ear effusions. METHODS: Twenty-seven rats underwent eustachian tube obstruction before ino culation of the middle ear bulla with PG-PS. Three weeks later, after resol ution of all middle ear effusions, 6 rats were randomly selected and euthan ized as the first control group (control I). The remaining 21 animals were randomly assigned to 3 groups that received intravenous injections of Krebs Ringer (control II), PG-PS, and LPS, respectively. These rats were euthani zed 2 days after intravenous injection. Middle ear mucin production and his tologic changes were measured in all animals. RESULTS: The mean concentrations of mucin were 0.94 +/- 0.52 mg/mL, 0.41 +/ - 0.87 mg/mL, 16.33 +/- 3.67 mg/mL, and 1.15 +/- 0.41 mg/mL in the control I, control II, PG-PS, and LPS groups, respectively. Thus the mean concentra tion of mucin in the middle ear lavage samples was significantly greater in rats that were injected intravenously with PG-PS than in rats in other gro ups (P < 0.05). Histologic analyses demonstrated a greater degree of goblet cell hyperplasia in the PG-PS group than in other groups. CONCLUSIONS: This is the first animal model of recurring otitis media with effusion in which a systemic injection of PG-PS was used to reactivate a mi ddle ear effusion in rats previously primed with a transtympanic injection of PG-PS, This study suggests that after otitis media with effusion has res olved, it may be reactivated by the presence of bacterial antigens and/or c ytokines in the systemic circulation.